LOL quote, "Why is the DeltaCell TM upgrading OCAT? "
"Upgrade"?? Where? It's a re-print of an existing article and contains no "upgrade"??
OCAT essentially has no analyst coverage for the most part- let alone any "upgrades" etc? Where?
A "trade mark", wow. How does that add value to a company or a stock? Anyone can file for a trademark on a name like "DeltaCell"- it's about a 10 minute form/piece of paper to fill out and mail in. What's it going to do to help the company pass large phase II and phase III clinical trials successfully? Has this "trade mark" gotten them any large funding? They can file "trade marks" for names till the cows come home- what difference does it make if they can't even fund their own key clinical trials and advance them as promised?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.